T Oshima

Summary

Country: Japan

Publications

  1. ncbi request reprint Role of nitric oxide in human gastric cancer cells treated with 5-fluorouracil
    T Oshima
    First Department of Surgery, Yokohama City University, School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama City, Kanagawa ken 236 0004, Japan
    Oncol Rep 8:847-9. 2001
  2. ncbi request reprint A case of primary mesenteric embryonal carcinoma
    Takashi Ohshima
    Yokohama City University Medical Center, Gastroenterological Center, Yokohama, Japan
    Hepatogastroenterology 51:983-6. 2004
  3. ncbi request reprint Overexpression of EphA4 gene and reduced expression of EphB2 gene: Correlation with liver metastasis in colorectal cancer
    T Oshima
    Yokohama City University Medical Center, Yokohama, Japan Kanagawa Cancer Center, Yokohama, Japan Yokohama City University, Yokohama, Japan
    J Clin Oncol 27:e15129. 2009
  4. ncbi request reprint Usefulness and faults of the sentinel lymph node biopsy using dye technique in distal gastrectomy for gastric cancer
    Y Rino
    Yokohama City University School of Medicine, Yokohama, Japan Yokohama City University Medical Center, Yokohama, Japan Yokohama City University Hospital, Yokohama, Japan
    J Clin Oncol 27:e15509. 2009
  5. doi request reprint A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic Treatment
    H Fujikawa
    Department of Gastrointestinal Surgery, Kanagawa Cancer Center KCCH, Yokohama, Japan
    Ann Surg Oncol 22:2317-22. 2015
  6. ncbi request reprint Can trastuzumab enhance the effectiveness of chemotherapy in patients with resected, HER2-positive, stage II/III, or stage IV gastric cancer?
    T Oshima
    Gastroenterological Center, Yokohama City University, Yokohama, Japan Department of Surgery, Yokohama City University, Yokohama, Japan
    J Clin Oncol 29:e14501. 2011
  7. ncbi request reprint Phase II trial of biweekly CPT-11 plus CDDP for patients with unresectable or recurrent gastric cancer refractory to S-1
    Y Rino
    Department of Surgery, Yokohama City University, Yokohama, Japan Gastroenterological Center, Yokohama City University, Yokohama, Japan Department of Surgery, Kamishirane Hospital, Yokohama, Japan Department of Surgery, Yokohama Minami Kyosai Hospital, Yokohama, Japan Kanagawa Ashigara Kami Hospital, Matsuda machi, Jordan Department of Surgery, Hiratsuka Kyosai Hospital, Hiratsuka, Japan
    J Clin Oncol 29:e14515. 2011
  8. doi request reprint Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer
    J Kimura
    Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan
    Dis Esophagus 29:1071-1080. 2016
  9. doi request reprint Diagnostic value of computed tomography for staging of clinical T1 gastric cancer
    H Fujikawa
    Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
    Ann Surg Oncol 21:3002-7. 2014

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Role of nitric oxide in human gastric cancer cells treated with 5-fluorouracil
    T Oshima
    First Department of Surgery, Yokohama City University, School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama City, Kanagawa ken 236 0004, Japan
    Oncol Rep 8:847-9. 2001
    ..5-FU induces NO production by gastric cancer cells, and NO participates in antitumor activity in gastric cancer cells. These effects may be mediated by TNF-alpha production...
  2. ncbi request reprint A case of primary mesenteric embryonal carcinoma
    Takashi Ohshima
    Yokohama City University Medical Center, Gastroenterological Center, Yokohama, Japan
    Hepatogastroenterology 51:983-6. 2004
    ..Primary mesenteric embryonal carcinoma is extremely rare. To our knowledge, no other cases have been reported. We describe this case and briefly discuss the related literature...
  3. ncbi request reprint Overexpression of EphA4 gene and reduced expression of EphB2 gene: Correlation with liver metastasis in colorectal cancer
    T Oshima
    Yokohama City University Medical Center, Yokohama, Japan Kanagawa Cancer Center, Yokohama, Japan Yokohama City University, Yokohama, Japan
    J Clin Oncol 27:e15129. 2009
    ..Over-expression of the EphA4 gene and reduced expression of the EphB2 gene may thus be a useful predictor of liver metastasis in patients with colorectal cancer. No significant financial relationships to disclose...
  4. ncbi request reprint Usefulness and faults of the sentinel lymph node biopsy using dye technique in distal gastrectomy for gastric cancer
    Y Rino
    Yokohama City University School of Medicine, Yokohama, Japan Yokohama City University Medical Center, Yokohama, Japan Yokohama City University Hospital, Yokohama, Japan
    J Clin Oncol 27:e15509. 2009
    ..Limited surgery is a procedure in which the extent of lesion resection and lymph node dissection is reduced. We assessed usefulness and faults of intraoperative diagnosis of lymph node metastasis in this regard...
  5. doi request reprint A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic Treatment
    H Fujikawa
    Department of Gastrointestinal Surgery, Kanagawa Cancer Center KCCH, Yokohama, Japan
    Ann Surg Oncol 22:2317-22. 2015
    ..The study was designed to predict reliably the patients without nodal metastasis based only on the clinical information...
  6. ncbi request reprint Can trastuzumab enhance the effectiveness of chemotherapy in patients with resected, HER2-positive, stage II/III, or stage IV gastric cancer?
    T Oshima
    Gastroenterological Center, Yokohama City University, Yokohama, Japan Department of Surgery, Yokohama City University, Yokohama, Japan
    J Clin Oncol 29:e14501. 2011
    ..We therefore examined whether trastuzumab can be expected to enhance the effectiveness of chemotherapy in patients with resected, HER2-positive, stage II/III or IV gastric cancer...
  7. ncbi request reprint Phase II trial of biweekly CPT-11 plus CDDP for patients with unresectable or recurrent gastric cancer refractory to S-1
    Y Rino
    Department of Surgery, Yokohama City University, Yokohama, Japan Gastroenterological Center, Yokohama City University, Yokohama, Japan Department of Surgery, Kamishirane Hospital, Yokohama, Japan Department of Surgery, Yokohama Minami Kyosai Hospital, Yokohama, Japan Kanagawa Ashigara Kami Hospital, Matsuda machi, Jordan Department of Surgery, Hiratsuka Kyosai Hospital, Hiratsuka, Japan
    J Clin Oncol 29:e14515. 2011
    ..25:1257-62, 2005). Therefore, we performed a phase II study to evaluate CPT-11+CDDP as the second line following S-1 single agent or S-1+CDDP failure...
  8. doi request reprint Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer
    J Kimura
    Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan
    Dis Esophagus 29:1071-1080. 2016
    ..However, a multicenter study as same regime with large number of patients will be needed to confirm these outcomes...
  9. doi request reprint Diagnostic value of computed tomography for staging of clinical T1 gastric cancer
    H Fujikawa
    Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
    Ann Surg Oncol 21:3002-7. 2014
    ..T1 gastric cancer can be diagnosed only by endoscopy and is almost curable by local treatment. It has been unclear how a multidetector-row computed tomography (CT) evaluation is valuable for clinical T1 patients...